Recent Patents of Interest in Proteomics
US Patent No. 8,401,800. Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity. Inventor: Marc Hellerstein. Assignee: University of California
Covers a method of measuring molecular flux rates within biomolecular processes involved in disease pathogenesis and comparing them between subjects and controls to obtain information on drug efficacy or toxicity.